nejm glp 1 Discovery of GLP-1–Based Drugs for the Treatment of Obesity Current Management of Glycemia in

Maestu I, Pastor M, Aparicio J, Oltra A, Herranz C, Montalar J et al

After 3 days of adaptation, d-allulose (1 g kg 1 ) or water (10 ml kg 1 ) was orally administered once daily at LP onset (7:30) for 10 days, and oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) were synchronously measured for 10 days

Pagets Disease of the Breast

An HbA1c target of less than 7.0% was attained by up to 80% with high-dose GLP-1 receptor agonists and up to 97% with tirzepatide (GLP-1/GIP receptor agonist), with even up to 62% of people with T2D reaching an HbA1c of less than 5.7%

The researchers described this as one proposed pathway by which C